296 related articles for article (PubMed ID: 35909975)
41. Structural basis for DARC binding in reticulocyte invasion by Plasmodium vivax.
Moskovitz R; Pholcharee T; DonVito SM; Guloglu B; Lowe E; Mohring F; Moon RW; Higgins MK
Nat Commun; 2023 Jun; 14(1):3637. PubMed ID: 37336887
[TBL] [Abstract][Full Text] [Related]
42. Naturally Acquired Human Antibodies Against Reticulocyte-Binding Domains of Plasmodium vivax Proteins, PvRBP2c and PvRBP1a, Exhibit Binding-Inhibitory Activity.
Gupta ED; Anand G; Singh H; Chaddha K; Bharti PK; Singh N; Sharma YD; Gaur D
J Infect Dis; 2017 May; 215(10):1558-1568. PubMed ID: 28379500
[TBL] [Abstract][Full Text] [Related]
43. Characterization of Duffy Binding Protein II-specific CD4
Thawornpan P; Malee C; Kochayoo P; Wangriatisak K; Leepiyasakulchai C; Ntumngia FB; De SL; Adams JH; Chootong P
Sci Rep; 2023 May; 13(1):7741. PubMed ID: 37173361
[TBL] [Abstract][Full Text] [Related]
44. Identification and Characterization of Functional Human Monoclonal Antibodies to
Carias LL; Dechavanne S; Nicolete VC; Sreng S; Suon S; Amaratunga C; Fairhurst RM; Dechavanne C; Barnes S; Witkowski B; Popovici J; Roesch C; Chen E; Ferreira MU; Tolia NH; Adams JH; King CL
J Immunol; 2019 May; 202(9):2648-2660. PubMed ID: 30944159
[No Abstract] [Full Text] [Related]
45. Genetic diversity, natural selection and haplotype grouping of Plasmodium vivax Duffy-binding protein genes from eastern and western Myanmar borders.
Hu Y; Wang L; Mbenda HGN; Soe MT; Yu C; Feng H; Kyaw MP; Cui L; Zhu X; Cao Y
Parasit Vectors; 2019 Nov; 12(1):546. PubMed ID: 31747970
[TBL] [Abstract][Full Text] [Related]
46. Dynamics of IgM and IgG responses to the next generation of engineered Duffy binding protein II immunogen: Strain-specific and strain-transcending immune responses over a nine-year period.
Medeiros CMP; Moreira EUM; Pires CV; Torres LM; Guimarães LFF; Alves JRS; Lima BAS; Fontes CJF; Costa HL; Brito CFA; Sousa TN; Ntumngia FB; Adams JH; Kano FS; Carvalho LH
PLoS One; 2020; 15(5):e0232786. PubMed ID: 32379804
[TBL] [Abstract][Full Text] [Related]
47. Independent Origin and Global Distribution of Distinct Plasmodium vivax Duffy Binding Protein Gene Duplications.
Hostetler JB; Lo E; Kanjee U; Amaratunga C; Suon S; Sreng S; Mao S; Yewhalaw D; Mascarenhas A; Kwiatkowski DP; Ferreira MU; Rathod PK; Yan G; Fairhurst RM; Duraisingh MT; Rayner JC
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005091. PubMed ID: 27798646
[TBL] [Abstract][Full Text] [Related]
48. Multiplexed Microsphere-Based Flow Cytometric Assay to Assess Strain Transcending Antibodies to
Alves JRS; de Araújo FF; Pires CV; Teixeira-Carvalho A; Lima BAS; Torres LM; Ntumngia FB; Adams JH; Kano FS; Carvalho LH
Front Immunol; 2021; 12():704653. PubMed ID: 34675915
[TBL] [Abstract][Full Text] [Related]
49. Strain-Transcending Inhibitory Antibodies against Homologous and Heterologous Strains of Duffy Binding Protein region II.
Wongkidakarn S; McHenry AM; Sattabongkot J; Adams JH; Chootong P
PLoS One; 2016; 11(5):e0154577. PubMed ID: 27145131
[TBL] [Abstract][Full Text] [Related]
50. Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial.
Singh K; Mukherjee P; Shakri AR; Singh A; Pandey G; Bakshi M; Uppal G; Jena R; Rawat A; Kumar P; Bhardwaj R; Yazdani SS; Hans D; Mehta S; Srinivasan A; Anil K; Madhusudhan RL; Patel J; Singh A; Rao R; Gangireddy S; Patil R; Kaviraj S; Singh S; Carter D; Reed S; Kaslow DC; Birkett A; Chauhan VS; Chitnis CE
NPJ Vaccines; 2018; 3():48. PubMed ID: 30302285
[TBL] [Abstract][Full Text] [Related]
51. Structural analysis of the synthetic Duffy Binding Protein (DBP) antigen DEKnull relevant for Plasmodium vivax malaria vaccine design.
Chen E; Salinas ND; Ntumngia FB; Adams JH; Tolia NH
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003644. PubMed ID: 25793371
[TBL] [Abstract][Full Text] [Related]
52. Plasmodium vivax Duffy binding protein: baseline antibody responses and parasite polymorphisms in a well-consolidated settlement of the Amazon Region.
Kano FS; Sanchez BA; Sousa TN; Tang ML; Saliba J; Oliveira FM; Nogueira PA; Gonçalves AQ; Fontes CJ; Soares IS; Brito CF; Rocha RS; Carvalho LH
Trop Med Int Health; 2012 Aug; 17(8):989-1000. PubMed ID: 22643072
[TBL] [Abstract][Full Text] [Related]
53. Whole genome sequencing of field isolates reveals a common duplication of the Duffy binding protein gene in Malagasy Plasmodium vivax strains.
Menard D; Chan ER; Benedet C; Ratsimbasoa A; Kim S; Chim P; Do C; Witkowski B; Durand R; Thellier M; Severini C; Legrand E; Musset L; Nour BY; Mercereau-Puijalon O; Serre D; Zimmerman PA
PLoS Negl Trop Dis; 2013 Nov; 7(11):e2489. PubMed ID: 24278487
[TBL] [Abstract][Full Text] [Related]
54. Acquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC).
Maestre A; Muskus C; Duque V; Agudelo O; Liu P; Takagi A; Ntumngia FB; Adams JH; Sim KL; Hoffman SL; Corradin G; Velez ID; Wang R
PLoS One; 2010 Jul; 5(7):e11437. PubMed ID: 20664684
[TBL] [Abstract][Full Text] [Related]
55. Genetic diversity in two Plasmodium vivax protein ligands for reticulocyte invasion.
Roesch C; Popovici J; Bin S; Run V; Kim S; Ramboarina S; Rakotomalala E; Rakotoarison RL; Rasoloharimanana T; Andriamanantena Z; Kumar A; Guillotte-Blisnick M; Huon C; Serre D; Chitnis CE; Vigan-Womas I; Menard D
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006555. PubMed ID: 30346980
[TBL] [Abstract][Full Text] [Related]
56. The biology of unconventional invasion of Duffy-negative reticulocytes by Plasmodium vivax and its implication in malaria epidemiology and public health.
Golassa L; Amenga-Etego L; Lo E; Amambua-Ngwa A
Malar J; 2020 Aug; 19(1):299. PubMed ID: 32831093
[TBL] [Abstract][Full Text] [Related]
57. Antibody responses and avidity of naturally acquired anti-Plasmodium vivax Duffy binding protein (PvDBP) antibodies in individuals from an area with unstable malaria transmission.
Zakeri S; Babaeekhou L; Mehrizi AA; Abbasi M; Djadid ND
Am J Trop Med Hyg; 2011 Jun; 84(6):944-50. PubMed ID: 21633032
[TBL] [Abstract][Full Text] [Related]
58. Using Plasmodium knowlesi as a model for screening Plasmodium vivax blood-stage malaria vaccine targets reveals new candidates.
Ndegwa DN; Kundu P; Hostetler JB; Marin-Menendez A; Sanderson T; Mwikali K; Verzier LH; Coyle R; Adjalley S; Rayner JC
PLoS Pathog; 2021 Jul; 17(7):e1008864. PubMed ID: 34197567
[TBL] [Abstract][Full Text] [Related]
59. Genetic mapping of the duffy binding protein (DBP) ligand domain of Plasmodium vivax from unstable malaria region in the Middle East.
Babaeekhou L; Zakeri S; Djadid ND
Am J Trop Med Hyg; 2009 Jan; 80(1):112-8. PubMed ID: 19141848
[TBL] [Abstract][Full Text] [Related]
60. Preclinical Assessment of Viral Vectored and Protein Vaccines Targeting the Duffy-Binding Protein Region II of Plasmodium Vivax.
de Cassan SC; Shakri AR; Llewellyn D; Elias SC; Cho JS; Goodman AL; Jin J; Douglas AD; Suwanarusk R; Nosten FH; Rénia L; Russell B; Chitnis CE; Draper SJ
Front Immunol; 2015; 6():348. PubMed ID: 26217340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
